Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-04-06Clinical Trial Update: Prospective Study With FLOT in Patients With Locally Advanced, Limited Metastatic or Extensive Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction [Phase 2]
Phase 2 prospective trial evaluating the FLOT regimen in locally advanced, limited metastatic, or extensive metastatic adenocarcinoma of the…
-
CLINICAL_TRIALS trial_result · 2016-04-04Clinical Trial Update: A Phase 3 Study of Rilotumumab (AMG 102) With Cisplatin and Capecitabine (CX) as First-line Therapy in Gastric Cancer [Phase 3]
Phase 3 study of rilotumumab with cisplatin and capecitabine for first-line gastric cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2016-03-29Clinical Trial Update: Effect of Peritoneal Lavage on Surgery-induced Positive Peritoneal Cytology in Gastric Cancer Patients [EARLY_Phase 1]
This completed EARLY_PHASE1 trial assessed whether peritoneal lavage affects surgery-induced positive peritoneal cytology in gastric cancer …
-
CLINICAL_TRIALS trial_result · 2016-03-29Clinical Trial Update: Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer [Phase 2]
Phase 2 trial evaluating everolimus in patients with previously treated unresectable or metastatic esophageal or gastric cancer has complete…
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric Cancer [Phase 1]
Phase 1 study of TKI 258 in combination with Xeloda (capecitabine) and oxaliplatin in advanced colorectal cancer and gastric cancer was term…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-24Clinical Trial Update: Effect of Gastrectomy and Anastomosis on Diabetes and Hypertension in Early Gastric Cancer Patients
A completed clinical trial evaluating how gastrectomy and reconstruction affect diabetes and hypertension in patients with early gastric can…
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: Study of Docetaxel, Cisplatin, and Fluorouracil (Modified DCF) With Bevacizumab in Patients With Unresectable or Metastatic Gastroesophageal Adenocarcinoma [Phase 2]
Phase 2 study of a modified docetaxel-cisplatin-5-FU regimen with bevacizumab in unresectable or metastatic gastroesophageal adenocarcinoma …
-
CLINICAL_TRIALS trial_result · 2016-03-14Clinical Trial Update: A Study of Herceptin (Trastuzumab) in Combination With Standard Chemotherapy in Patients With HER Positive Metastatic Gastric Cancer [Phase 4]
A Phase 4 study of Herceptin (trastuzumab) in combination with standard chemotherapy for HER2-positive metastatic gastric cancer was termina…
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer [Phase 2]
This Phase 2 trial evaluated adding adjuvant intraperitoneal floxuridine to chemoradiation after complete resection in advanced gastric canc…
-
CLINICAL_TRIALS trial_result · 2016-03-11Clinical Trial Update: The Study of Surgery,Chemotherapy and Autologous T Cells-Based Immunotherapy for Advanced Gastric Cancer. [EARLY_Phase 1]
An early-phase 1 clinical trial evaluating surgery, chemotherapy, and autologous T cell–based immunotherapy for advanced gastric cancer is i…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Clinical Safety and Preliminary Efficacy of AAV-DC-CTL Treatment in Stage IV Gastric Cancer [Phase 1]
A Phase 1 clinical trial assesses the safety and preliminary efficacy of AAV-DC-CTL therapy in patients with stage IV gastric cancer.
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: Effect of Midazolam Premedication on the Satisfaction Levels of Patients After Endoscopic Submucosal Dissection [NA]
Completed clinical trial evaluating whether midazolam premedication improves patient satisfaction after endoscopic submucosal dissection in …
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: A Phase I-II Study of HM781-36B Combined With Paclitaxel and Trastuzumab in HER-2 Positive Advanced Gastric Cancer [Phase 1, Phase 2]
This document reports the completion of a Phase I–II clinical trial evaluating HM781-36B in combination with paclitaxel and trastuzumab for …
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Phase 1/1b Study of Rilotumumab in Japanese Subjects With Advanced Solid Tumors or Advanced or Metastatic Gastric or GEJ [Phase 1]
Phase 1/1b trial of rilotumumab in Japanese patients with advanced solid tumors and advanced or metastatic gastric or GEJ cancer has complet…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: A Study of Ramucirumab in Treating Japanese Participants With Metastatic Gastric or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial of ramucirumab in Japanese patients with metastatic gastric or gastroesophageal junction cancer has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2016-02-15Clinical Trial Update: The Efficacy of Serum Pepsinogen for Prediction of Metachronous Gastric Neoplasm
A completed clinical trial evaluated whether serum pepsinogen can predict metachronous gastric neoplasms in patients with gastric cancer. Th…
-
CLINICAL_TRIALS trial_result · 2016-02-11Clinical Trial Update: Docetaxel+Oxali+/-Cetux Met Gastric/GEJ [Phase 2]
Phase 2 trial assessed docetaxel plus oxaliplatin, with or without cetuximab, in metastatic gastric/GEJ adenocarcinoma; results were posted …
-
CLINICAL_TRIALS trial_result · 2016-02-09Clinical Trial Update: First-Line Treatment for Locally Advanced or Metastatic Mesenchymal Epithelial Transition Factor (MET) - Positive Gastric, Lower Esophageal, or Gastroesophageal Junction (GEJ) Adenocarcinoma [Phase 3]
Amgen's Phase 3 trial evaluating rilotumumab for MET-positive gastric/GEJ adenocarcinoma was terminated, indicating the study did not procee…
-
CLINICAL_TRIALS trial_result · 2016-02-08Clinical Trial Update: A Study of Docetaxel in Combination With Capecitabine in Stomach and Esophagus Cancers [Phase 2]
A Phase 2 trial of docetaxel in combination with capecitabine for gastric and esophageal cancers was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: No Antimicrobial Prophylaxis for Laparoscopic Distal Gastrectomy [Phase 2]
A Phase 2 clinical trial evaluates whether antimicrobial prophylaxis can be omitted during laparoscopic distal gastrectomy for gastric cance…
-
CLINICAL_TRIALS trial_result · 2016-02-03Clinical Trial Update: Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma [Phase 2]
Phase 2 trial assessing preoperative chemotherapy with bevacizumab and PET-guided salvage therapy in locally advanced but resectable gastric…
-
CLINICAL_TRIALS trial_result · 2016-02-02Clinical Trial Update: Compliance to ERAS After Gastric Surgery [Phase 2]
Phase 2 clinical trial completed; reports on adherence to Enhanced Recovery After Surgery (ERAS) protocols following gastric surgery for sto…
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Irinotecan as 3rd Line Therapy in Gastric Cancer [Phase 2]
Phase 2 clinical trial evaluating irinotecan as third-line therapy for gastric cancer, with the trial status currently unknown.
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer [Phase 2]
A Phase 2 clinical trial evaluated chemotherapy with or without vismodegib in patients with advanced stomach or gastroesophageal junction ad…
-
CLINICAL_TRIALS trial_result · 2016-01-25Clinical Trial Update: T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System [Phase 1]
Phase 1 clinical trial evaluating a HER2-positive T cell–mediated adaptive therapy for digestive-system cancers, including esophageal, gastr…